Recent Earnings News
Where is AMRS's stock going now?
Down
Flat
Up
AMRS

Amyris Sees Revenue Above Estimates

Tuesday, March 2, 2021 8:28:00 AM

Amyris (AMRS) reported a 4th Quarter December 2020 loss of $0.44 per share on revenue of $79.7 million. The consensus estimate was a loss of $0.11 per share on revenue of $67.2 million. Revenue grew 96.7% on a year-over-year basis.

The company said it expects 2021 revenue of approximately $240.0 million, prior to any strategic transactions. The current consensus revenue estimate is $231.8 million for the year ending December 31, 2021.

Amyris Inc is a renewable products company engaged in providing sustainable alternatives to petroleum-sourced products. It developed microbial engineering and screening technologies that modify the way microorganisms process sugars.

Amyris Sees Revenue Above Estimates Earnings Whispers
Where is NNOX's stock going now?
Down
Flat
Up
NNOX

Nano-X Imaging reports

Tuesday, March 2, 2021 8:00:00 AM

Nano-X Imaging (NNOX) reported a 4th Quarter December 2020 loss of $0.18 per share. The consensus estimate was a loss of $0.13 per share.

Nanox, founded by the serial entrepreneur Ran Poliakine, is an Israeli corporation that is developing a commercial-grade digital X-ray source designed to be used in real-world medical imaging applications. Nanox believes that its novel technology could significantly reduce the costs of medical imaging systems and plans to seek collaborations with world-leading healthcare organizations and companies to provide affordable, early detection imaging service for all.

Nano-X Imaging reports Earnings Whispers
Where is GLYC's stock going now?
Down
Flat
Up
GLYC

Glycomimetics Misses

Tuesday, March 2, 2021 7:30:00 AM

Glycomimetics (GLYC) reported a 4th Quarter December 2020 loss of $0.32 per share on revenue of $0.2 million. The consensus estimate was a loss of $0.32 per share on revenue of $1.0 million. The Earnings Whisper number was for a loss of $0.26 per share.

GlycoMimetics Inc is a clinical stage biotechnology company. The Company is engaged in discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role.

Glycomimetics Misses Earnings Whispers
Where is KOPN's stock going now?
Down
Flat
Up
KOPN

Kopin Cp reports

Tuesday, March 2, 2021 7:30:00 AM

Kopin Cp (KOPN) reported 4th Quarter December 2020 earnings of $0.02 per share on revenue of $13.9 million. The consensus estimate was a loss of $0.02 per share on revenue of $9.2 million. Revenue grew 59.5% on a year-over-year basis.

Kopin Corp is a developer of Wearable technologies and display products. Wearable technologies are used to create hands-free voice and gesture controlled wireless computing and communication systems.

Kopin Cp reports Earnings Whispers
Where is ANF's stock going now?
Down
Flat
Up
ANF

Abercrombie & Fitch Beats

Tuesday, March 2, 2021 7:30:00 AM

Abercrombie & Fitch (ANF) reported 4th Quarter January 2021 earnings of $1.50 per share on revenue of $1.1 billion. The consensus earnings estimate was $1.20 per share on revenue of $1.1 billion. The Earnings Whisper number was $1.34 per share.

Abercrombie & Fitch Co is a specialty retailer, which operates stores and direct-to-consumer operations. The Company sells products, including casual sportswear apparel, including knit and woven shirts, and graphic t-shirts.

Abercrombie & Fitch Beats Earnings Whispers
Where is KSS's stock going now?
Down
Flat
Up
KSS

Kohl's Beats

Tuesday, March 2, 2021 7:00:00 AM

Kohl's (KSS) reported 4th Quarter January 2021 earnings of $2.22 per share on revenue of $6.1 billion. The consensus earnings estimate was $1.04 per share on revenue of $6.1 billion. The Earnings Whisper number was $1.05 per share.

The company said it expects fiscal 2022 earnings of $2.45 to $2.95 per share on revenue of approximately $18.35 billion. The current consensus earnings estimate is $2.70 per share on revenue of $18.27 billion for the year ending January 31, 2022.

Kohl' Corp operates department stores that sell moderately priced exclusive and national brand apparel, footwear, accessories, beauty and home products.

Kohl's Beats Earnings Whispers
Where is MCRB's stock going now?
Down
Flat
Up
MCRB

Seres Theraptc reports

Tuesday, March 2, 2021 7:00:00 AM

Seres Theraptc (MCRB) reported a 4th Quarter December 2020 loss of $0.18 per share on revenue of $17.6 million. The consensus estimate was a loss of $0.26 per share on revenue of $8.8 million. Revenue grew 130.4% on a year-over-year basis.

Seres Theraptc reports Earnings Whispers
Where is TXMD's stock going now?
Down
Flat
Up
TXMD

Therapeuticsmd Misses

Tuesday, March 2, 2021 7:00:00 AM

Therapeuticsmd (TXMD) reported a 4th Quarter December 2020 loss of $0.15 per share on revenue of $22.6 million. The consensus estimate was a loss of $0.10 per share on revenue of $21.3 million. The Earnings Whisper number was for a loss of $0.09 per share. Revenue grew 42.0% on a year-over-year basis.

TherapeuticsMD Inc is a specialty pharmaceutical company. It develops and markets branded prescription, generic prescription, and over-the-counter (non-prescription) products exclusively for women.

Therapeuticsmd Misses Earnings Whispers
Where is AZO's stock going now?
Down
Flat
Up
AZO

Autozone Beats

Tuesday, March 2, 2021 6:55:00 AM

Autozone (AZO) reported 2nd Quarter February 2021 earnings of $14.93 per share on revenue of $2.9 billion. The consensus earnings estimate was $13.07 per share on revenue of $2.7 billion. The Earnings Whisper number was $13.30 per share.

AutoZone Inc is a retailer and distributor of automotive replacement parts and accessories in the United States. The Company operates stores which carries an extensive product line for cars, sport utility vehicles, vans and light trucks and among others.

Autozone Beats Earnings Whispers
Where is EGRX's stock going now?
Down
Flat
Up
EGRX

Eagle Pharmaceuticals Beats

Tuesday, March 2, 2021 6:50:00 AM

Eagle Pharmaceuticals (EGRX) reported 4th Quarter December 2020 earnings of $1.85 per share on revenue of $49.9 million. The consensus estimate was a loss of $0.17 per share on revenue of $50.1 million. The Earnings Whisper number was $0.05 per share. Revenue grew 3.4% on a year-over-year basis.

Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. It develops and commercializes injectable products primarily in the critical care and oncology areas.

Eagle Pharmaceuticals Beats Earnings Whispers
Where is SE's stock going now?
Down
Flat
Up
SE

Sea Ltd ADR reports

Tuesday, March 2, 2021 6:30:00 AM

Sea Ltd ADR (SE) reported a 4th Quarter December 2020 loss of $0.87 per share on revenue of $1.6 billion. The consensus estimate was a loss of $0.57 per share on revenue of $1.7 billion. Revenue grew 101.6% on a year-over-year basis.

Spectra Energy Corp. through its subsidiaries and equity affiliates owns and operates a portfolio of complementary natural gas-related energy assets. It also own and operate a crude oil pipeline system.

Sea Ltd ADR reports Earnings Whispers
Where is TGT's stock going now?
Down
Flat
Up
TGT

Target Misses

Tuesday, March 2, 2021 6:30:00 AM

Target (TGT) reported 4th Quarter January 2021 earnings of $2.67 per share on revenue of $28.3 billion. The consensus earnings estimate was $2.53 per share on revenue of $27.5 billion. The Earnings Whisper number was $3.15 per share.

Target Corp is engaged in operating general merchandise discount stores in the United States.

Target Misses Earnings Whispers
Where is LL's stock going now?
Down
Flat
Up
LL

Lumber Liquidators Holdings Beats

Tuesday, March 2, 2021 6:00:00 AM

Lumber Liquidators Holdings (LL) reported 4th Quarter December 2020 earnings of $1.06 per share on revenue of $304.2 million. The consensus earnings estimate was $0.52 per share on revenue of $299.4 million. The Earnings Whisper number was $0.67 per share. Revenue grew 11.1% on a year-over-year basis.

Lumber Liquidators Holdings Inc is a specialty retailer of hardwood flooring in North America. It offers products including domestic hardwood species, engineered hardwood, laminate, vinyl plank, bamboo and cork.

Lumber Liquidators Holdings Beats Earnings Whispers
Where is DDD's stock going now?
Down
Flat
Up
DDD

3D Systems Misses

Monday, March 1, 2021 7:45:00 PM

3D Systems (DDD) reported 4th Quarter December 2020 earnings of $0.08 per share on revenue of $172.7 million. The consensus earnings estimate was $0.09 per share on revenue of $171.8 million. The Earnings Whisper number was $0.14 per share. Revenue grew 4.9% on a year-over-year basis.

3D Systems Corp through its subsidiaries is engaged in providing 3D printing centric solutions, including 3D printers, print materials and cloud sourced custom parts.

3D Systems Misses Earnings Whispers
Where is LMND's stock going now?
Down
Flat
Up
LMND

Lemonade Beats

Monday, March 1, 2021 5:35:00 PM

Lemonade (LMND) reported a 4th Quarter December 2020 loss of $0.60 per share on revenue of $20.5 million. The consensus estimate was a loss of $0.65 per share on revenue of $19.3 million. The Earnings Whisper number was for a loss of $0.61 per share.

The company said in its shareholders letter it expects first quarter revenue of $21.5 million to $22.5 million and 2021 revenue of $114.0 million to $117.0 million. The current consensus revenue estimate is $22.07 million for the quarter ending March 31, 2021 and revenue of $112.60 million for the year ending December 31, 2021.

Lemonade Beats Earnings Whispers
Where is NIO's stock going now?
Down
Flat
Up
NIO

Nio Misses

Monday, March 1, 2021 5:00:00 PM

Nio (NIO) reported a 4th Quarter December 2020 loss of $0.14 per share on revenue of $1.0 billion. The consensus estimate was a loss of $0.07 per share. The Earnings Whisper number was for a loss of $0.03 per share. Revenue grew 148.8% on a year-over-year basis.

The company said it expects first quarter revenue of $1.1314 billion to $1.1582 billion. The current consensus revenue estimate is $718.5 million for the quarter ending March 31, 2021.

Nio Misses Earnings Whispers
Where is AI's stock going now?
Down
Flat
Up
AI

C3.ai Sees Revenue Above Estimates

Monday, March 1, 2021 4:38:00 PM

C3.Ai Inc Cl A (AI) reported a 3rd Quarter January 2021 loss of $0.23 per share on revenue of $49.1 million. The consensus estimate was a loss of $0.17 per share on revenue of $47.6 million.

The company said it expects fourth quarter revenue of $50.0 million to $51.0 million. The current consensus revenue estimate is $48.56 million for the quarter ending April 30, 2021. said it expects fourth quarter revenue of $50.0 million to $51.0 million. The current consensus revenue estimate is $48.56 million for the quarter ending April 30, 2021.

C3.ai, Inc. (NYSE:AI) is a leading provider of Enterprise AI software for accelerating digital transformation. C3 AI delivers a family of fully integrated products: C3 AI® Suite, an end-to-end platform for developing, deploying, and operating large-scale AI applications; C3 AI Applications, a portfolio of industry-specific SaaS AI applications; C3 AI CRM, a suite of industry-specific CRM applications designed for AI and machine learning; and C3 AI Ex Machina, a no-code AI solution to apply data science to everyday business problems. The core of the C3 AI offering is an open, model-driven AI architecture that dramatically simplifies data science and application development.

C3.ai Sees Revenue Above Estimates Earnings Whispers
Where is MELI's stock going now?
Down
Flat
Up
MELI

Mercadolibre Misses

Monday, March 1, 2021 4:18:00 PM

Mercadolibre (MELI) reported a 4th Quarter December 2020 loss of $1.02 per share on revenue of $1.3 billion. The consensus earnings estimate was $0.39 per share on revenue of $1.2 billion. The Earnings Whisper number was $0.47 per share. Revenue grew 96.9% on a year-over-year basis.

Mercadolibre Inc together with its subsidiaries hosts the online commerce platform in Latin America, which is focused on enabling e-commerce and its related services.

Mercadolibre Misses Earnings Whispers
Where is INO's stock going now?
Down
Flat
Up
INO

Inovio Pharma Beats

Monday, March 1, 2021 4:15:00 PM

Inovio Pharma (INO) reported a 4th Quarter December 2020 loss of $0.14 per share on revenue of $5.6 million. The consensus estimate was a loss of $0.22 per share on revenue of $1.0 million. The Earnings Whisper number was for a loss of $0.19 per share. Revenue grew 1,893.2% on a year-over-year basis.

Inovio Pharmaceuticals Inc is a clinical stage biopharmaceutical company. The Company develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases.

Inovio Pharma Beats Earnings Whispers
Where is CYRX's stock going now?
Down
Flat
Up
CYRX

Cryoport reports

Monday, March 1, 2021 4:13:00 PM

Cryoport (CYRX) reported a 4th Quarter December 2020 loss of $0.28 per share on revenue of $48.4 million. The consensus estimate was a loss of $0.15 per share on revenue of $43.3 million. Revenue grew 423.3% on a year-over-year basis.

CryoPort Inc provides frozen shipping logistics solutions to the life sciences industry.

Cryoport reports Earnings Whispers
Where is APPF's stock going now?
Down
Flat
Up
APPF

Appfolio Cl A reports

Monday, March 1, 2021 4:10:00 PM

Appfolio Cl A (APPF) reported a 4th Quarter December 2020 loss of $0.01 per share on revenue of $72.4 million. The consensus earnings estimate was $0.13 per share on revenue of $74.0 million. Revenue grew 7.5% on a year-over-year basis.

Appfolio Cl A reports Earnings Whispers
Where is ZM's stock going now?
Down
Flat
Up
ZM

Zoom Video Communications Cl A Beats

Monday, March 1, 2021 4:05:00 PM

Zoom Video Communications Cl A (ZM) reported 4th Quarter January 2021 earnings of $1.22 per share on revenue of $882.5 million. The consensus earnings estimate was $0.79 per share on revenue of $809.1 million. The Earnings Whisper number was $0.90 per share.

The company said it expects first quarter non-GAAP earnings of $0.95 to $0.97 per share on revenue of $900.0 million to $905.0 million and fiscal 2022 earnings of $3.59 to $3.65 per share on revenue of $3.76 billion to $3.78 billion. The current consensus estimate is earnings of $0.75 per share on revenue of $829.94 million for the quarter ending April 30, 2021 and earnings of $2.96 per share on revenue of $3.53 billion for the year ending January 31, 2022.

Zoom Video Communications Cl A Beats Earnings Whispers
Where is SWCH's stock going now?
Down
Flat
Up
SWCH

Switch Sees Revenue below Estimates

Monday, March 1, 2021 4:05:00 PM

Switch (SWCH) reported 4th Quarter December 2020 earnings of $0.06 per share on revenue of $127.7 million. The consensus earnings estimate was $0.05 per share on revenue of $131.1 million. Revenue grew 6.0% on a year-over-year basis.

The company said it expects 2021 revenue of $540.0 million to $555.0 million. The current consensus revenue estimate is $571.12 million for the year ending December 31, 2021.

Switch Sees Revenue below Estimates Earnings Whispers
Where is PGEN's stock going now?
Down
Flat
Up
PGEN

Precigen reports

Monday, March 1, 2021 4:05:00 PM

Precigen (PGEN) reported a 4th Quarter December 2020 loss of $0.11 per share on revenue of $19.3 million. The consensus estimate was a loss of $0.16 per share on revenue of $23.1 million. Revenue grew 13.7% on a year-over-year basis.

Precigen reports Earnings Whispers
Where is RGNX's stock going now?
Down
Flat
Up
RGNX

Regenxbio reports

Monday, March 1, 2021 4:05:00 PM

Regenxbio (RGNX) reported a 4th Quarter December 2020 loss of $1.24 per share on revenue of $21.4 million. The consensus earnings estimate was $1.11 per share on revenue of $129.8 million. Revenue grew 82.2% on a year-over-year basis.

Regenxbio reports Earnings Whispers
Where is SRPT's stock going now?
Down
Flat
Up
SRPT

Sarepta Therapeutics reports

Monday, March 1, 2021 4:05:00 PM

Sarepta Therapeutics (SRPT) reported a 4th Quarter December 2020 loss of $2.40 per share on revenue of $145.1 million. The consensus estimate was a loss of $2.00 per share on revenue of $142.7 million. Revenue grew 45.0% on a year-over-year basis.

Sarepta Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare, infectious and other diseases.

Sarepta Therapeutics reports Earnings Whispers
Where is AGRX's stock going now?
Down
Flat
Up
AGRX

Agile Therap reports

Monday, March 1, 2021 4:05:00 PM

Agile Therap (AGRX) reported a 4th Quarter December 2020 loss of $0.20 per share on revenue of $0.7 million. The consensus estimate was a loss of $0.23 per share on revenue of $1.0 million.

Agile Therapeutics Inc is a women' health speciality pharmaceutical company. It develops and commercializes new prescription contraceptive products.

Agile Therap reports Earnings Whispers
Where is AMRC's stock going now?
Down
Flat
Up
AMRC

Ameresco Guides Revenue Above Estimates

Monday, March 1, 2021 4:05:00 PM

Ameresco (AMRC) reported 4th Quarter December 2020 earnings of $0.47 per share on revenue of $314.3 million. The consensus earnings estimate was $0.30 per share on revenue of $262.6 million. Revenue grew 2.5% on a year-over-year basis.

The company said it expects 2021 earnings of $1.18 to $1.26 per share on revenue of $1.10 billion to $1.15 billion. The current consensus earnings estimate is $1.21 per share on revenue of $1.05 billion for the year ending December 31, 2021.

Ameresco, Inc. is an independent provider of comprehensive services, energy efficiency, infrastructure upgrades, asset sustainability and renewable energy solutions for businesses and organizations throughout North America and Europe.

Ameresco Guides Revenue Above Estimates Earnings Whispers
Where is INSG's stock going now?
Down
Flat
Up
INSG

Inseego Misses

Monday, March 1, 2021 4:03:00 PM

Inseego (INSG) reported a 4th Quarter December 2020 loss of $0.07 per share on revenue of $86.1 million. The consensus estimate was for breakeven results on revenue of $84.6 million. The Earnings Whisper number was $0.02 per share. Revenue grew 64.5% on a year-over-year basis.

Inseego Misses Earnings Whispers
Where is NVAX's stock going now?
Down
Flat
Up
NVAX

Novavax reports

Monday, March 1, 2021 4:02:00 PM

Novavax (NVAX) reported a 4th Quarter December 2020 loss of $2.70 per share on revenue of $279.7 million. The consensus estimate was a loss of $1.53 per share on revenue of $211.9 million. Revenue grew 3,072.2% on a year-over-year basis.

Novavax Inc is a clinical-stage vaccine company engaged in the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants.

Novavax reports Earnings Whispers
Where is WKHS's stock going now?
Down
Flat
Up
WKHS

Workhorse Grp Beats

Monday, March 1, 2021 9:00:00 AM

Workhorse Grp (WKHS) reported 4th Quarter December 2020 earnings of $0.25 per share on revenue of $0.7 million. The consensus estimate was a loss of $0.12 per share on revenue of $1.3 million. The Earnings Whisper number was for a loss of $0.20 per share. Revenue grew 21,633.3% on a year-over-year basis.

Workhorse Grp Beats Earnings Whispers
Where is TGT's stock going now?
Down
Flat
Up
TGT

Target Misses

Monday, March 1, 2021 8:00:00 AM

Target (TGT) reported 4th Quarter January 2021 earnings of $2.67 per share on revenue of $28.3 billion. The consensus earnings estimate was $2.53 per share on revenue of $27.5 billion. The Earnings Whisper number was $3.15 per share.

Target Corp is engaged in operating general merchandise discount stores in the United States.

Target Misses Earnings Whispers
Where is NRG's stock going now?
Down
Flat
Up
NRG

NRG Energy Misses

Monday, March 1, 2021 7:34:00 AM

NRG Energy (NRG) reported a 4th Quarter December 2020 loss of $0.53 per share on revenue of $2.0 billion. The consensus earnings estimate was $0.37 per share. The Earnings Whisper number was $0.49 per share. Revenue fell 7.7% compared to the same quarter a year ago.

The company said it continues to expect Adjusted EBITDA of $2.40 billion to $2.60 billion for the year ending December 31, 2021.

NRG Energy Inc is engaged in ownership & operation of power generation facilities; the trading of energy, capacity & related products; transacting in & trading of fuel & transportation services & the direct sale of energy, services to retail customers.

NRG Energy Misses Earnings Whispers
Where is SSYS's stock going now?
Down
Flat
Up
SSYS

Stratasys Beats

Monday, March 1, 2021 7:30:00 AM

Stratasys (SSYS) reported 4th Quarter December 2020 earnings of $0.13 per share on revenue of $142.4 million. The consensus estimate was for breakeven results on revenue of $135.4 million. The Earnings Whisper number was $0.02 per share. Revenue fell 11.1% compared to the same quarter a year ago.

The company said it expects first quarter revenue of approximately $132.9 million. The current consensus revenue estimate is $129.75 million for the quarter ending March 31, 2021.

Stratasys Ltd provides additive manufacturing solutions for the creation of parts used in the processes of designing and manufacturing products and for the direct manufacture of end parts. It offers 3D printers and 3D production systems.

Stratasys Beats Earnings Whispers
Where is TGNA's stock going now?
Down
Flat
Up
TGNA

Tegna Misses

Monday, March 1, 2021 7:30:00 AM

Tegna (TGNA) reported 4th Quarter December 2020 earnings of $1.16 per share on revenue of $937.6 million. The consensus earnings estimate was $1.19 per share on revenue of $933.0 million. The Earnings Whisper number was $1.21 per share. Revenue grew 35.1% on a year-over-year basis.

The company said it expects 2021 revenue of approximately $3.08 billion. The current consensus revenue estimate is $2.84 billion for the year ending December 31, 2021.

Tegna Misses Earnings Whispers
Where is BHVN's stock going now?
Down
Flat
Up
BHVN

Biohaven Pharmaceutical Holding Company reports

Monday, March 1, 2021 7:30:00 AM

Biohaven Pharmaceutical Holding Company (BHVN) reported a 4th Quarter December 2020 loss of $3.62 per share on revenue of $35.1 million. The consensus estimate was a loss of $2.89 per share on revenue of $35.0 million.

Biohaven Pharmaceutical Holding Company reports Earnings Whispers
Where is FOLD's stock going now?
Down
Flat
Up
FOLD

Amicus Therapeutics Misses

Monday, March 1, 2021 7:00:00 AM

Amicus Therapeutics (FOLD) reported a 4th Quarter December 2020 loss of $0.27 per share on revenue of $70.6 million. The consensus estimate was a loss of $0.24 per share. The Earnings Whisper number was for a loss of $0.26 per share. Revenue grew 27.6% on a year-over-year basis.

The company said it expects 2021 revenue of at least $300.0 million to $315.0 million. The current consensus revenue estimate is $328.7 million for the year ending December 31, 2021.

Amicus Therapeutics Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of next-generation medicines for orphan diseases.

Amicus Therapeutics Misses Earnings Whispers
Where is CVET's stock going now?
Down
Flat
Up
CVET

Covetrus Reaffirms

Monday, March 1, 2021 7:00:00 AM

Covetrus (CVET) reported 4th Quarter December 2020 earnings of $0.14 per share on revenue of $1.1 billion. The consensus earnings estimate was $0.10 per share on revenue of $1.1 billion. Revenue grew 11.2% on a year-over-year basis.

The company said it continues to expect Adjusted EBITDA of $240.0 million to $250.0 million for the year ending December 1, 2021.

Covetrus Reaffirms Earnings Whispers
Where is MORF's stock going now?
Down
Flat
Up
MORF

Morphic Holding reports

Monday, March 1, 2021 6:55:00 AM

Morphic Holding (MORF) reported a 4th Quarter December 2020 loss of $0.57 per share on revenue of $5.9 million. The consensus estimate was a loss of $0.37 per share on revenue of $8.0 million. Revenue grew 1,672.1% on a year-over-year basis.

Morphic Holding reports Earnings Whispers
Where is RETA's stock going now?
Down
Flat
Up
RETA

Reata Pharma reports

Monday, March 1, 2021 6:35:00 AM

Reata Pharma (RETA) reported a 4th Quarter December 2020 loss of $1.90 per share on revenue of $3.2 million. The consensus estimate was a loss of $2.14 per share on revenue of $1.4 million. Revenue grew 19.5% on a year-over-year basis.

Reata Pharma reports Earnings Whispers
Where is CWEN's stock going now?
Down
Flat
Up
CWEN

Clearway Energy Inc Cl C Misses

Monday, March 1, 2021 6:29:00 AM

Clearway Energy Inc Cl C (CWEN) reported 4th Quarter December 2020 earnings of $0.11 per share on revenue of $280.0 million. The consensus earnings estimate was $0.86 per share on revenue of $296.0 million. The Earnings Whisper number was $0.96 per share. Revenue grew 19.1% on a year-over-year basis.

Clearway Energy Inc Cl C Misses Earnings Whispers
Where is THRM's stock going now?
Down
Flat
Up
THRM

Gentherm Beats

Monday, March 1, 2021 6:00:00 AM

Gentherm (THRM) reported 4th Quarter December 2020 earnings of $1.16 per share on revenue of $288.9 million. The consensus earnings estimate was $0.65 per share on revenue of $250.7 million. The Earnings Whisper number was $0.71 per share. Revenue grew 25.4% on a year-over-year basis.

The company said it expects 2021 revenue of $1.05 billion to $1.13 billion. The current consensus revenue estimate is $1.02 billion for the year ending December 31, 2021.

Gentherm Inc is engaged in the design, development, and manufacturing of thermal management technologies. The Company has two reportable segments for financial reporting purposes: Automotive and Industrial.

Gentherm Beats Earnings Whispers
Where is BRK.B's stock going now?
Down
Flat
Up
BRK.B

Berkshire Hathaway Cl B reports

Saturday, February 27, 2021 8:00:00 AM

Berkshire Hathaway Cl B (BRK.B) reported 4th Quarter December 2020 earnings of $2.15 per share on revenue of $64.4 billion. The consensus earnings estimate was $2.34 per share. Revenue fell 1.5% compared to the same quarter a year ago.

Berkshire Hathaway Cl B reports Earnings Whispers
Where is AMRS's stock going now?
Down
Flat
Up
AMRS

Amyris reports

Friday, February 26, 2021 10:50:00 PM

Amyris (AMRS) reported a 4th Quarter December 2020 loss of $0.44 per share on revenue of $79.7 million. The consensus estimate was a loss of $0.11 per share on revenue of $67.2 million. Revenue grew 96.7% on a year-over-year basis.

Amyris Inc is a renewable products company engaged in providing sustainable alternatives to petroleum-sourced products. It developed microbial engineering and screening technologies that modify the way microorganisms process sugars.

Amyris reports Earnings Whispers
Where is CRON's stock going now?
Down
Flat
Up
CRON

Cronos Group Misses

Friday, February 26, 2021 7:30:00 AM

Cronos Group (CRON) reported a 4th Quarter December 2020 loss of $0.19 per share on revenue of $17.0 million. The consensus estimate was a loss of $0.06 per share on revenue of $13.8 million. The Earnings Whisper number was for a loss of $0.04 per share. Revenue grew 115.4% on a year-over-year basis.

Cronos Group Misses Earnings Whispers
Where is AMCX's stock going now?
Down
Flat
Up
AMCX

Amc Networks Cl A Beats

Friday, February 26, 2021 7:00:00 AM

Amc Networks Cl A (AMCX) reported 4th Quarter December 2020 earnings of $2.72 per share on revenue of $780.3 million. The consensus earnings estimate was $0.59 per share on revenue of $713.7 million. The Earnings Whisper number was $0.56 per share. Revenue fell 0.6% compared to the same quarter a year ago.

AMC Networks Inc owns and operates several of cable television’s brands delivering high quality content to audiences and a valuable platform to distributors and advertisers.

Amc Networks Cl A Beats Earnings Whispers
Where is BLDR's stock going now?
Down
Flat
Up
BLDR

Builders Firstsource Beats

Friday, February 26, 2021 7:00:00 AM

Builders Firstsource (BLDR) reported 4th Quarter December 2020 earnings of $1.26 per share on revenue of $2.5 billion. The consensus earnings estimate was $0.92 per share on revenue of $2.7 billion. The Earnings Whisper number was $1.03 per share. Revenue grew 43.5% on a year-over-year basis.

The company said it expects 2021 revenue of $13.90 billion to $14.60 billion. The current consensus revenue estimate is $13.20 billion for the year ending December 31, 2021.

Builders FirstSource Inc is a supplier and manufacturer of structural and related building products for residential new construction in the United States.

Builders Firstsource Beats Earnings Whispers
Where is DKNG's stock going now?
Down
Flat
Up
DKNG

Draftkings Misses

Friday, February 26, 2021 7:00:00 AM

Draftkings (DKNG) reported a 4th Quarter December 2020 loss of $0.69 per share on revenue of $322.2 million. The consensus estimate was a loss of $0.57 per share on revenue of $229.7 million. The Earnings Whisper number was for a loss of $0.55 per share.

The company said it expects 2021 revenue of $900.0 million to $1.0 billion. The company's previous guidance was revenue of $750.0 million to $850.0 million and the current consensus revenue estimate is $823.81 million for the year ending December 31, 2021.

Draftkings Misses Earnings Whispers
Where is FLR's stock going now?
Down
Flat
Up
FLR

Fluor Misses

Friday, February 26, 2021 6:50:00 AM

Fluor (FLR) reported a 4th Quarter December 2020 loss of $0.82 per share on revenue of $3.7 billion. The consensus earnings estimate was $0.11 per share on revenue of $3.7 billion. The Earnings Whisper number was $0.26 per share.

The company said it expects 2021 earnings of $0.50 to $0.80 per share. The current consensus earnings estimate is $0.97 per share for the year ending December 31, 2021.

Fluor Corp through its subsidiaries engages in professional services providing engineering, procurement, construction and maintenance as well as project management services.

Fluor Misses Earnings Whispers
Where is FL's stock going now?
Down
Flat
Up
FL

Footlocker Reports In-line

Friday, February 26, 2021 6:45:00 AM

Footlocker (FL) reported 4th Quarter January 2021 earnings of $1.55 per share on revenue of $2.2 billion. The consensus earnings estimate was $1.36 per share on revenue of $2.3 billion. The Earnings Whisper number was $1.55 per share.

Foot Locker Inc is a retailer of athletically inspired shoes and apparel, operating primarily mall-based stores in the United States, Canada, Europe, Australia, and New Zealand.

Footlocker Reports In-line Earnings Whispers
Where is AMRX's stock going now?
Down
Flat
Up
AMRX

Amneal Pharmaceuticals Misses

Friday, February 26, 2021 6:00:00 AM

Amneal Pharmaceuticals (AMRX) reported 4th Quarter December 2020 earnings of $0.11 per share on revenue of $510.0 million. The consensus earnings estimate was $0.12 per share on revenue of $502.2 million. The Earnings Whisper number was $0.20 per share. Revenue grew 28.4% on a year-over-year basis.

The company said it expects 2021 non-GAAP earnings of $0.70 to $0.85 per share on revenue of $2.10 billion to $2.20 billion. The current consensus earnings estimate is $0.72 per share on revenue of $2.04 billion for the year ending December 31, 2021.

Amneal Pharmaceuticals Misses Earnings Whispers